Founded in 2020, IntegriMedical is a healthcare technology company on a mission to revolutionize drug delivery by eliminating the fear, discomfort, and safety risks associated with conventional needle-based injections.
For millions across the globe, the sight of a needle is enough to induce anxiety, especially in children. Yet, needle-based injections remain the dominant method of drug delivery—even as safer, more comfortable alternatives have begun to emerge. But one Pune-based med-tech startup is working to take the dread out of necessary injections. Founded in 2020 by Sarvesh Mutha, Ankur Naik, Scott McFarland, and Mark Timm, IntegriMedical is on a mission to reimagine how medications are delivered.
Their answer: a needle-free, spring-driven device that administers drugs through the skin using a high-pressure jet, minimizing trauma and eliminating the risks associated with traditional injections. Born from firsthand experience The idea for IntegriMedical was rooted in founder Sarvesh Mutha’s experience in the healthcare and medical device industries. “Needle phobia is more than just fear—it can cause patients to skip life-saving treatments,” says Mutha, now the company’s Managing Director.
The issue also extends to healthcare workers, who are routinely exposed to needle-stick injuries and the risks of cross-contamination. Determined to develop a safer alternative, Mutha joined forces with co-founders Ankur Naik—an expert in device design and regulatory compliance; Scott McFarland—a healthcare veteran with deep experience in finance and delivery; and Mark Timm—a seasoned entrepreneur in global supply chain operations.
“Together, we envisioned a future where drug delivery would be painless, sustainable, and more accessible,” says Mutha . Painless injection process The Needle-Free Injection System (N-FIS) is built around a stainless-steel piston mechanism that delivers medications intramuscularly or subcutaneously in under a tenth of a second.
“Instead of a needle, the device uses a disposable cartridge with an orifice finer than a strand of human hair to create a precise jet stream. The result is a nearly painless experience that also reduces the risk of cross-contamination, tissue damage, and hazardous medical waste,” explains Mutha.
The Pune-based startup received CDSCO approval for N-FIS in December 2022 and launched it commercially in April 2024 after pilot testing. The device is backed by regulatory approvals including CE, ISO 13485, and MDSAP, and is protected by a US patent.
Source: YourStory
#healthcarestartup #dseidehealthcarenetwork
For millions across the globe, the sight of a needle is enough to induce anxiety, especially in children. Yet, needle-based injections remain the dominant method of drug delivery—even as safer, more comfortable alternatives have begun to emerge. But one Pune-based med-tech startup is working to take the dread out of necessary injections. Founded in 2020 by Sarvesh Mutha, Ankur Naik, Scott McFarland, and Mark Timm, IntegriMedical is on a mission to reimagine how medications are delivered.
Their answer: a needle-free, spring-driven device that administers drugs through the skin using a high-pressure jet, minimizing trauma and eliminating the risks associated with traditional injections. Born from firsthand experience The idea for IntegriMedical was rooted in founder Sarvesh Mutha’s experience in the healthcare and medical device industries. “Needle phobia is more than just fear—it can cause patients to skip life-saving treatments,” says Mutha, now the company’s Managing Director.
The issue also extends to healthcare workers, who are routinely exposed to needle-stick injuries and the risks of cross-contamination. Determined to develop a safer alternative, Mutha joined forces with co-founders Ankur Naik—an expert in device design and regulatory compliance; Scott McFarland—a healthcare veteran with deep experience in finance and delivery; and Mark Timm—a seasoned entrepreneur in global supply chain operations.
“Together, we envisioned a future where drug delivery would be painless, sustainable, and more accessible,” says Mutha . Painless injection process The Needle-Free Injection System (N-FIS) is built around a stainless-steel piston mechanism that delivers medications intramuscularly or subcutaneously in under a tenth of a second.
“Instead of a needle, the device uses a disposable cartridge with an orifice finer than a strand of human hair to create a precise jet stream. The result is a nearly painless experience that also reduces the risk of cross-contamination, tissue damage, and hazardous medical waste,” explains Mutha.
The Pune-based startup received CDSCO approval for N-FIS in December 2022 and launched it commercially in April 2024 after pilot testing. The device is backed by regulatory approvals including CE, ISO 13485, and MDSAP, and is protected by a US patent.
Source: YourStory
#healthcarestartup #dseidehealthcarenetwork
Founded in 2020, IntegriMedical is a healthcare technology company on a mission to revolutionize drug delivery by eliminating the fear, discomfort, and safety risks associated with conventional needle-based injections.
For millions across the globe, the sight of a needle is enough to induce anxiety, especially in children. Yet, needle-based injections remain the dominant method of drug delivery—even as safer, more comfortable alternatives have begun to emerge. But one Pune-based med-tech startup is working to take the dread out of necessary injections. Founded in 2020 by Sarvesh Mutha, Ankur Naik, Scott McFarland, and Mark Timm, IntegriMedical is on a mission to reimagine how medications are delivered.
Their answer: a needle-free, spring-driven device that administers drugs through the skin using a high-pressure jet, minimizing trauma and eliminating the risks associated with traditional injections. Born from firsthand experience The idea for IntegriMedical was rooted in founder Sarvesh Mutha’s experience in the healthcare and medical device industries. “Needle phobia is more than just fear—it can cause patients to skip life-saving treatments,” says Mutha, now the company’s Managing Director.
The issue also extends to healthcare workers, who are routinely exposed to needle-stick injuries and the risks of cross-contamination. Determined to develop a safer alternative, Mutha joined forces with co-founders Ankur Naik—an expert in device design and regulatory compliance; Scott McFarland—a healthcare veteran with deep experience in finance and delivery; and Mark Timm—a seasoned entrepreneur in global supply chain operations.
“Together, we envisioned a future where drug delivery would be painless, sustainable, and more accessible,” says Mutha . Painless injection process The Needle-Free Injection System (N-FIS) is built around a stainless-steel piston mechanism that delivers medications intramuscularly or subcutaneously in under a tenth of a second.
“Instead of a needle, the device uses a disposable cartridge with an orifice finer than a strand of human hair to create a precise jet stream. The result is a nearly painless experience that also reduces the risk of cross-contamination, tissue damage, and hazardous medical waste,” explains Mutha.
The Pune-based startup received CDSCO approval for N-FIS in December 2022 and launched it commercially in April 2024 after pilot testing. The device is backed by regulatory approvals including CE, ISO 13485, and MDSAP, and is protected by a US patent.
Source: YourStory
#healthcarestartup #dseidehealthcarenetwork
